SRPT

Sarepta Therapeutics Inc

22.50

-0.49-2.13%

Pre Market: 19.00 -3.50 -15.56%06:17 09/08 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE22.58/22.99

TODAY RANGE21.98-22.65

VOL69.49K

MARKET CAP2.38B

52 WEEK RANGE14.68-25.32

AVG VOL (3M)3.34M

% TURNOVER2.80%

TURNOVER0

P/E (TTM)-13.5412

% RANGE2.89%

EPS(TTM)-1.6616

P/E(FORWARD)7.21

P/B1.556

BVPS14.46

DIVIDEND--

P/S1.074

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP2.26B

SHARES OUTSTANDING105.63M

NEXT EARNINGS11/02-11/06

FREE FLOAT100.42M

LOT SIZE1

EX-DATE07/12/2012

News

Press Releases

Financial Reports

Profile

Seeking Alpha·54m ago
Biggest stock movers Tuesday: ZIM, NVS, and more
Seeking Alpha·1h ago
Novartis drops 13% on trial failure, dragging Dyne and Sarepta
Seeking Alpha·5d ago
Most shorted stocks on Wall Street
Seeking Alpha·5d ago
Most and least shorted mid- to mega-cap healthcare stocks at the end of August
TipRanks·5d ago
J.P. Morgan Remains a Hold on Sarepta Therapeutics (SRPT)
Seeking Alpha·08/28 11:35
Sarepta: A Prove-It Story Now Defined By ELEVIDYS Execution
TipRanks·08/27 16:31
Sarepta’s ENHANCE Study: Post-Marketing Safety Push for ELEVIDYS Could Shape SRPT’s Next Leg
NASDAQ·08/24 16:53
KROS $20M Takeda Milestone Adds Cash but Revenue Visibility Stays Weak
NASDAQ·08/24 16:51
Should You Buy KROS Stock as Pipeline Promise Meets Revenue Risk?
Barron‘s·08/24 12:39
Regenxbio Stock Sinks 22% Following Surprise Finding in Gene Therapy Trial
TipRanks·08/10 12:45
Evercore ISI Reaffirms Their Hold Rating on Sarepta Therapeutics (SRPT)
TipRanks·08/07 13:40
Unusually active option classes on open August 7th
TipRanks·08/07 08:48
Barclays Reaffirms Their Hold Rating on Sarepta Therapeutics (SRPT)
TipRanks·08/07 00:04
Sarepta Therapeutics Balances Profit Gains With Revenue Strain
TipRanks·08/06 15:00
Analysts Offer Insights on Healthcare Companies: Compass Therapeutics (CMPX), Revolution Medicines (RVMD) and Sarepta Therapeutics (SRPT)

Same Industry

Name/Symbol

Change%

Price

McKesson

MCK

-1.45%

907.99

Biogen Inc

BIIB

-1.64%

220.83

AMGN

Shire

SHPG

0.00%

179.20

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

-6.69%

0.1380

LLY

Celgene

CELG

0.00%

108.24

TXMD

Johnson & Johnson

JNJ

-1.15%

275.23

Abbvie Inc

ABBV

-1.44%

256.46

Zoetis Inc

ZTS

-0.63%

75.81

GILD

Novo-Nordisk A/S

NVO

-1.92%

46.60

Bristol-Myers Squibb Co

BMY

-1.87%

66.82

ALXN

Pfizer

PFE

-1.25%

28.45

SNY

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

-1.90%

159.99

RDY

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.